Aurora Spine Corporation Schedules Release of Third Quarter Fiscal Year 2022 Financial Results and Conference Call
November 15, 2022 19:19 ET
|
Aurora Spine Corporation
CARLSBAD, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices...
Aurora Spine Corporation Announces Positive Interim Results from Clinical Study using ZIP™ MIS Interspinous Fusion System
October 27, 2022 07:15 ET
|
Aurora Spine Corporation
CARLSBAD, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices...
Aurora Spine Corporation to Attend the North American Spine Society (NASS) Annual Meeting
October 11, 2022 07:15 ET
|
Aurora Spine Corporation
CARLSBAD, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices...
Aurora Spine Receives 2022 Best New Spine Technology Award for its DEXA bone density-matched spine implant innovation
October 11, 2022 07:00 ET
|
Aurora Spine Corporation
CARLSBAD, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices...
Aurora Spine Corporation Announces FDA 510(k) Clearance for its SiLO TFX™ MIS Sacroiliac Joint Fixation System
October 06, 2022 07:15 ET
|
Aurora Spine Corporation
CARLSBAD, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices...
Aurora Spine Corporation Announces FDA 510(k) Clearance for its SiLO TFX™ MIS Sacroiliac Joint Fixation System
October 04, 2022 17:53 ET
|
Aurora Spine Corporation
CARLSBAD, Calif., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices...
Aurora Spine Corporation to Participate in the Lytham Partners Fall 2022 Investor Conference
September 20, 2022 10:48 ET
|
Aurora Spine Corporation
CARLSBAD, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices...
Aurora Spine Corporation Announces Record Second Quarter Fiscal 2022 Financial Results
August 29, 2022 07:15 ET
|
Aurora Spine Corporation
Management to host conference call today, August 29, 2022 at 11:00 AM ET CARLSBAD, Calif. , Aug. 29, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the...
Aurora Spine Corporation Schedules Release of Second Quarter Fiscal Year 2022 Financial Results and Conference Call
August 22, 2022 07:15 ET
|
Aurora Spine Corporation
CARLSBAD, Calif., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices...
Aurora Spine Announces New FDA indication clearance of Lumbar Spinal Stenosis for its ZIP™ series of MIS implants
July 12, 2022 07:15 ET
|
Aurora Spine Corporation
CARLSBAD, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants, today...